Women’s Health Practice – Multi-Physician OB/GYN and Urogynecology Clinic

This is a rare opportunity to acquire a well-established, multi-physician women’s health practice in one of Florida’s fastest-growing healthcare markets. The clinic operates as a comprehensive women’s health destination, combining OB/GYN, urogynecology, robotic and laparoscopic surgery, and a rich suite of in-office procedures under one roof. With two physicians currently on staff, two additional physicians actively being recruited and expected to join in 2026, and a deep bench of mid-level providers, this is not a solo-physician practice. It is a platform built to grow.

Business Overview

Founded over two decades ago, this practice has built a loyal patient base and a strong reputation in its market as the go-to destination for women’s health across all life stages. The clinic sees patients for everything from routine gynecology and preventive care to complex urogynecological surgery, in-office procedures, diagnostic ultrasound, and urodynamics testing. All robotic and laparoscopic surgeries are performed at a local hospital, while a comprehensive menu of in-office procedures, including hysteroscopy, endometrial ablation, colposcopy, LEEP, bladder Botox, cystoscopy, and more, is performed directly at the clinic, generating strong ancillary revenue that is not dependent on hospital scheduling.

The practice is fully supported by a professional third-party management company that handles all billing, HR, compliance, regulatory, and accounting functions under a single contract, keeping operations lean and management overhead low for any incoming owner.

Key Investment Highlights

• Exceptional and proven financial performance. The practice has delivered 18% average annual revenue growth from 2021 through 2025 and carries adjusted EBITDA margins of approximately 49%. Very few healthcare practices at this size generate this level of profitability consistently over a multi-year period.
• Multi-physician, not solo dependent. The practice currently operates with two physicians on staff. Two additional physicians are actively in the hiring process and expected to join by late 2026. Mid-levels handle the majority of day-to-day clinical volume, which means the practice does not live or die on any one provider’s schedule.
• Massive near-term growth already in motion. 2026 projected revenue of $8.1M represents 27% growth over 2025, driven entirely by organic additions already underway. New physician hires, a mid-level surgical expansion, and a urodynamics volume ramp from current levels to 13 studies per week are all in progress today.
• 8-month surgical backlog in urogynecology. Demand already exceeds current capacity. This is not speculative growth – it is documented unmet demand that a buyer can monetize immediately by adding providers.
• Premium commercial payer mix. 82% of insurance receipts come from commercial carriers, with BCBS, Aetna, UHC, and Cigna as the top payers. Government payer exposure is only 18%, which is well below average for a Florida women’s health practice and reflects a higher-reimbursing patient population.
• Rich ancillary revenue that any GYN can perform. Diagnostic ultrasound interpretation, in-office procedures, and urodynamics generate significant revenue that is not physician-specific. Any credentialed provider added to the practice can perform and bill for these services, making the ancillary revenue stream highly scalable and transferable.
• Compelling expansion runway. The practice operates from a single location and has not yet explored satellite offices, nearby market expansion, or a second location. The demand, brand, and operational infrastructure are all in place to support geographic expansion with the right buyer. Orlando has been identified as a natural adjacent market.
• Full financial transparency and institutional-quality diligence package. A comprehensive financial model, multi-year historical financials, revenue bridge analysis, payer mix breakdown, capacity analysis, and physician-level revenue attribution have been prepared to help any serious buyer make a fully informed decision with confidence.

Reason for Sale and Seller Transition

The founder is selling to refocus on family and reduce her personal workload, not because the business is slowing down. She has committed to remaining with the practice as an employed physician through Q1 2029, providing meaningful continuity for patients, staff, and the incoming owner. During that transition period she will continue performing surgeries and procedures and is committed to supporting a smooth handover. She is not walking away; instead, she’s stepping back from ownership while remaining clinically engaged.

Why this deal is so compelling right now: 

The practice is in the middle of its most significant growth phase in its history. Two new physicians are joining. Mid-level surgical capacity is expanding. The urodynamics program is scaling up. A buyer who closes in 2026 steps directly into an operation that is already accelerating; they do not have to engineer the growth; they simply have to fund and support what is already in motion. The projected return at a market-based multiple is exceptional.

Ideal Buyer Profile

The seller is looking to partner with someone who understands the healthcare and women’s health space; a physician group, a private equity-backed platform, a DSO-style consolidator moving into women’s health, or a high-net-worth individual with relevant operating experience. We prefer cash-heavy buyers who can close quickly and do not rely entirely on SBA financing to fund the transaction. Buyers who can move decisively and treat the seller with respect will stand out. An earnout is the seller’s last preference; maximum cash at close is the priority. The seller wants this to go to someone who will take care of her staff, her patients, and the practice she has spent over 20 years building

This listing will move quickly. A full diligence package including the financial model, historical P&Ls, payer mix analysis, and revenue bridge is available to qualified buyers under NDA. To learn more or to receive the information memorandum, please fill out the NDA